Table 1.
Case # | Gene | Varianta | Clinical fit with variant | ACMGb grade | ABC-Ac grade | ABC-Bc grade | % reported after ACMG Incl maybe | % reported after ACMG excl maybe | % reported after ABC |
---|---|---|---|---|---|---|---|---|---|
1 | CHEK2 | p.(Ile200Thr) | Good | 3,5 - VUS | 4,3 - LFE | 2,3 - RF | 83 | 71 | 91 |
2 | CACNA1A | p.(Arg1437Gln) | Good | 3,2 - VUS | 3,1 - HFE | 1,9 - RF | 95 | 81 | 95 |
3 | ADAMTS18 |
p.(Arg246Ter) p.(Arg573Pro) |
Excellent |
4,3 - LP 3,3 - VUS |
4,4 - LFE 3,1 - HFE |
3,1 - P 2,0 - RF |
95 | 95 | 100 |
4 | HUWE1 | p.(Glu4315Lys) | Good | 3,3 - VUS | 3,4 - HFE | 1,9- RF | 95 | 74 | 100 |
5 | COL5A1 | Thr915Met | Good | 2,9 - VUS | 2,6 - HFE | 1,5 - VOI | 80 | 54 | 79 |
6 | Deletion of ANK2 | 1 Mb de novo deletion | ? Normal fetus | 3,8 - LP | 3,6 - LFE | 0,8 - VOI | 67 | 57 | 65 |
7 | Duplication of 16p11.2 | 227 kb duplication | Moderate | 3,1 - VUS | 3,0 - HFE | 1,5 - VOI | 71 | 60 | 79 |
8 | PTPN11 | p.(Gly268Ser) | Poor | 4,2 - LP | 3,9 - LFE | 1,2 - VOI | 64 | 50 | 67 |
9 | TNFRSF1A | p.(Arg121Gln) | Moderate | 2,6 - VUS | 3,1 - HFE | 2,0 - RF | 64 | 40 | 81 |
10 | ABCA4 | p.(Asn1868Ile) | Excellent | 2,7 - VUS | 3,6 - LFE | 1,8 - RF | 67 | 50 | 86 |
LP likely pathogenic, VUS variant of unknown significance, LFE likely functional effect, HFE hypothetical functional effect, RF risk factor, VOI variant of interest, P pathogenic.
aFor variant details, see Supplementary File S1.
bThe ACMG grades are the average of the grades given by all participating laboratories, see Supplementary File S2 for details. Please note that to be able to calculate this, ACMG classes were converted to numbers: P = 5, LP = 4, VUS = 3, LB = 2 and B = 1.
cABC grades are the average of ABC-A and ABC-B grading, see Supplementary File S2 for details.